Literature DB >> 8070360

Histaminergic activation of the hypothalamic-pituitary-adrenal axis.

A Kjaer1, P J Larsen, U Knigge, J Warberg.   

Abstract

Centrally administered histamine (HA) stimulates the secretion of adenohypophysial POMC-derived peptides, which subsequently cause release of corticosterone. The effect of HA on POMC-derived peptide release is indirect, and it is possible that hypothalamic neurons containing corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), or oxytocin (OT) are involved in the mediation of this response. We studied the effect of HA on: 1) expression of CRH, AVP, and OT messenger RNA (mRNA) at the hypothalamic level; 2) expression of c-fos and POMC mRNA at the pituitary level; and 3) peripheral plasma levels of AVP, OT, ACTH, beta-endorphin (beta-END), and corticosterone. HA (270 nmol) infused intracerebroventricularly increased the expression of CRH, AVP, and OT mRNA in the paraventricular nucleus as well as that of OT mRNA in the supraoptic nucleus of the hypothalamus. At the pituitary level the expression of mRNA for c-fos and POMC increased in the anterior but not in the intermediate lobe in response to HA. Plasma levels of AVP, OT, ACTH, beta-END, and corticosterone all increased in response to central HA administration. Circulating levels of AVP and OT peaked after 5 min, ACTH and beta-END after 15 min, whereas corticosterone levels were highest after 30 min. In concert with our earlier discoveries, the present data support the hypothesis that HA-induced secretion of ACTH and beta-END is mediated via central activation of hypothalamic neuroendocrine neurons containing CRH, AVP, and/or OT.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070360     DOI: 10.1210/endo.135.3.8070360

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Dipsogenic potentiation by sodium chloride but not by sucrose or polyethylene glycol in tuberomammillary-mediated polydipsia.

Authors:  J Mahía; A Bernal; A Puerto
Journal:  Exp Brain Res       Date:  2007-07-14       Impact factor: 1.972

2.  Evidence for the involvement of histaminergic neurones in the regulation of the rat oxytocinergic system during pregnancy and parturition.

Authors:  S M Luckman; P J Larsen
Journal:  J Physiol       Date:  1997-06-15       Impact factor: 5.182

3.  Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus.

Authors:  David M Krolewski; Adriana Medina; Ilan A Kerman; Rene Bernard; Sharon Burke; Robert C Thompson; William E Bunney; Alan F Schatzberg; Richard M Myers; Huda Akil; Edward G Jones; Stanley J Watson
Journal:  J Comp Neurol       Date:  2010-11-15       Impact factor: 3.215

4.  Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes : a pilot study.

Authors:  Yuen Yi Hon; William J Jusko; Hong-Hao Zhou; Guo-Lin Chen; Dong Guo; Gan Zhou; Vicky E Spratlin; Michael W Jann
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Authors:  Fumikazu Yokoyama; Miki Yamauchi; Masayo Oyama; Kunihiro Okuma; Kaname Onozawa; Takako Nagayama; Rie Shinei; Makoto Ishikawa; Yasuo Sato; Nobukazu Kakui
Journal:  Psychopharmacology (Berl)       Date:  2009-04-09       Impact factor: 4.530

6.  Altered methylprednisolone pharmacodynamics in healthy subjects with histamine N-methyltransferase C314T genetic polymorphism.

Authors:  Yuen Yi Hon; William J Jusko; Vicky E Spratlin; Michael W Jann
Journal:  J Clin Pharmacol       Date:  2006-04       Impact factor: 3.126

7.  Procognitive impact of ciproxifan (a histaminergic H3 receptor antagonist) on contextual memory retrieval after acute stress.

Authors:  Frédéric Chauveau; Elodie De Job; Betty Poly-Thomasson; Raphaël Cavroy; Julien Thomasson; Dominique Fromage; Daniel Beracochea
Journal:  CNS Neurosci Ther       Date:  2019-05-15       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.